Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes
NCT ID: NCT01771939
Last Updated: 2013-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2006-10-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD
NCT04139811
The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane
NCT02210481
Choroidal Thickness Vitrectomy
NCT02617147
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
NCT04278079
Outcomes Based on the Pre-operative Integrity of IS/OS Junction in Idiopathic Epimacular Membrane Surgery
NCT04158791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
idiopathic epiretinal membranes
Patients in first arm, with worse visual condition, treated with 25-G Vitrectomy and phacoemulsification (cataract intervention)
25-G vitrectomy and phacoemulsification
25-G vitrectomy with Internal Limiting Membrane peeling and phacoemulsification (cataract intervention)
idiopathic epiretinal membrane
Patient in second arm, with better pre-operative condition, treated with phacoemulsification (cataract intervention) only
phacoemulsification (cataract surgery)
lens extraction after phacoemulsification and intra-ocular artificial lens implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
25-G vitrectomy and phacoemulsification
25-G vitrectomy with Internal Limiting Membrane peeling and phacoemulsification (cataract intervention)
phacoemulsification (cataract surgery)
lens extraction after phacoemulsification and intra-ocular artificial lens implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turin, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marco Dal Vecchio
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Dal Vecchio, MD
Role: PRINCIPAL_INVESTIGATOR
Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy 10100
Antonio M. Fea, MD, PhD
Role: STUDY_CHAIR
Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy
Carlo A Lavia, MD
Role: PRINCIPAL_INVESTIGATOR
Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Oculistica dell'Università, Ospedale Oftalmico
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VTCMER2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.